| Hans-Günter Meyer-Thompson | Hepatitiden
Long-term risk of hepatocellular carcinoma in HCV patients treated with direct acting antiviral agents.
Long-term risk of hepatocellular carcinoma in HCV patients treated with direct acting antiviral agents.
Kanwal F, Kramer JR, Asch SM, Cao Y, Li L, El-Serag HB.
Hepatology. 2019 Jun 20. doi: 10.1002/hep.30823.